Perennial Investment Advisors LLC bought a new position in shares of Merck KGaA (OTCMKTS:MKGAF – Free Report) in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund bought 5,358 shares of the company’s stock, valued at approximately $689,000.
A number of other institutional investors have also added to or reduced their stakes in the stock. Frazier Financial Advisors LLC bought a new stake in Merck KGaA during the 2nd quarter worth $25,000. Rakuten Securities Inc. acquired a new position in shares of Merck KGaA during the second quarter worth $27,000. Solstein Capital LLC acquired a new stake in Merck KGaA in the second quarter valued at $33,000. Delos Wealth Advisors LLC bought a new stake in shares of Merck KGaA in the 2nd quarter valued at about $33,000. Finally, Burk Holdings LLC acquired a new position in shares of Merck KGaA in the second quarter worth approximately $39,000. 0.10% of the stock is currently owned by institutional investors and hedge funds.
Merck KGaA Stock Up 0.4%
Shares of OTCMKTS MKGAF opened at $164.58 on Thursday. Merck KGaA has a 52-week low of $116.68 and a 52-week high of $175.56. The company’s 50 day moving average price is $163.19 and its 200-day moving average price is $148.83. The company has a market capitalization of $21.27 billion, a P/E ratio of 25.13 and a beta of 0.96. The company has a debt-to-equity ratio of 0.27, a quick ratio of 0.84 and a current ratio of 1.31.
About Merck KGaA
Merck KGaA, headquartered in Darmstadt, Germany, is a long-established multinational chemical and pharmaceutical company with roots dating back to 1668. Operating under the brand Merck Group (and using distinct consumer-facing names in certain regions to avoid confusion with other companies of similar name), the company is privately controlled by the Merck family and organizes its activities across multiple business units that serve customers in Europe, the Americas, Asia-Pacific and beyond.
The company’s operations are organized mainly into three businesses.
Featured Stories
- Five stocks we like better than Merck KGaA
- Williams-Sonoma’s Quarter Gave Bulls More Than Just a Beat-and-Raise
- Alcoa’s Gallium Project Opens a New Door Beyond Aluminum
- Oura’s $16 Billion IPO Could Put a New Price on Wearable Tech
- Can Tesla’s Flying Roadster Distract From Its Real Risks?
Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.
